April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Inhibition of Retinoblastoma in vitro and in vivo With Conditionally Replicating Oncolytic Adenovirus H101
X. Song; X. Fan; R. Jia; Y. Zhou; X. Xu; H. Wang; S. Ge
Author Affiliations & Notes
  • X. Song
    Ophthalmology, Shanghai 9th People's Hospital, Shanghai, China
  • X. Fan
    Ophthalmology, Shanghai 9th People's Hospital, Shanghai, China
  • R. Jia
    Ophthalmology, Shanghai 9th People's Hospital, Shanghai, China
  • Y. Zhou
    Ophthalmology, Shanghai 9th People's Hospital, Shanghai, China
  • X. Xu
    Ophthalmology, Shanghai 9th People's Hospital, Shanghai, China
  • H. Wang
    Department of Biochemistry and Molecular Biology, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • S. Ge
    Department of Biochemistry and Molecular Biology, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • Footnotes
    Commercial Relationships  X. Song, None; X. Fan, None; R. Jia, None; Y. Zhou, None; X. Xu, None; H. Wang, None; S. Ge, None.
  • Footnotes
    Support  Shanghai Leading Academic Discipline Project S30205 ; Science and Technology Commission of Shanghai 08410702300
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1693. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Inhibition of Retinoblastoma in vitro and in vivo With Conditionally Replicating Oncolytic Adenovirus H101
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      X. Song, X. Fan, R. Jia, Y. Zhou, X. Xu, H. Wang, S. Ge; Inhibition of Retinoblastoma in vitro and in vivo With Conditionally Replicating Oncolytic Adenovirus H101. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1693.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To determine the functional effects of oncolytic adenovirus H101 on retinoblastoma in vitro and in vivo.

Methods: : The expression of Coxsackie-adenovirus receptor (CAR) in the human retinoblastoma cell line HXO-RB44 was determined by reverse transcription polymerase chain reaction (RT-PCR). Retinoblastoma cells were incubated with green fluorescent protein (GFP)-labeled adenovirus (AdGFP) and appropriate multiplicity of infection (MOI) was determined using flow cytometry. Cell viability of HXO-RB44 treated with H101 or AdGFP was measured using a CCK8-based procedure. Viral proliferation was measured through endpoint dilution titration on 293 human embryonic kidney cells and real-time PCR. Cell cycle and apoptosis were analyzed by flow cytometry. NOD-SCID mice bearing retinoblastoma xenografts were treated with intratumoral injection of H101, AdGFP, or phosphate-buffered saline. Tumor volume and survival time were recorded. Immunohistochemistry for adenoviral fiber protein in paraffin-embedded tissue sections of retinoblastoma xenografts was performed to evaluate H101 virus replication in vivo.

Results: : HXO-RB44 cells extensively expressed CAR and were sensitive to adenoviral infection. HXO-RB44 cells treated with H101 had dramatically reduced cell viability compared with AdGFP-treated cells (P<0.01). Abundant replication of H101 was observed in HXO-RB44 cells, resulting in G2/M phase arrest, but there was no apoptosis. Tumor-bearing mice treated with H101 had significantly reduced tumor volume (68%) and significantly prolonged survival time (170%) compared with controls (both P<0.01). Immunohistochemical examination revealed widespread replication of H101 within the tumor.

Conclusions: : These results suggest that oncolytic adenovirus H101 effectively inhibits retinoblastoma cells in vitro and in vivo, and may be useful for the clinical treatment of retinoblastoma.

Keywords: retinoblastoma • gene transfer/gene therapy • adenovirus 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×